Daily BriefsTMT/Internet

Daily Brief TMT/Internet: Taiwan Semiconductor (TSMC) – ADR, Alibaba (ADR), Chipmos Technologies, Asia Vital Components and more

In today’s briefing:

  • Taiwan Dual-Listings Monitor: TSMC Post-CNY Spread Persisting; Why UMC Discount Could Flip Positive
  • ECM Weekly (26th Feb 2024) – Trial Holdings, Juniper, Xiaocaiyuan, Union Bank, Orica, Azure
  • ChipMOS: Valuation at Risk Given Latest Results; Short Interest Shows Sentiment Has Room to Shift
  • Asia Vital Components (3017) – Sunday, Nov 26, 2023


Taiwan Dual-Listings Monitor: TSMC Post-CNY Spread Persisting; Why UMC Discount Could Flip Positive

By Vincent Fernando, CFA

  • TSMC: +17.3% Premium, High Double Digit Level Persisting Since CNY
  • UMC: -1.5% Discount, We Believe Spread Biased to Go Positive
  • ChipMOS: +0.6% Premium, Collapsed from +4.6%. Now Within Typical Range.

ECM Weekly (26th Feb 2024) – Trial Holdings, Juniper, Xiaocaiyuan, Union Bank, Orica, Azure

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, we looked at Trial Holdings (5882 JP) refiling and Xiaocaiyuan International Holding .
  • For placements, it was an action packed week in India, again, with Australia joining in as well.

ChipMOS: Valuation at Risk Given Latest Results; Short Interest Shows Sentiment Has Room to Shift

By Vincent Fernando, CFA

  • ChipMOS Margin Rebound Sputters, Guidance Implies Margins Could Remain Under Pressure
  • Valuation Appears Precarious In Light of Latest Results and Guidance
  • Valuation Appears Precarious In Light of Latest Results and Guidance

Asia Vital Components (3017) – Sunday, Nov 26, 2023

By Value Investors Club

Key points

  • AI is a rapidly growing trend in the global market, with Taiwanese manufacturer AVC experiencing significant growth in their stock value.
  • AVC has shown strong financial performance in recent years, with impressive average revenue and margin metrics.
  • The company is expected to continue its growth trend in 2023, with higher margins than historical averages, as the impact of technology and COVID has been beneficial for AVC.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars